Nafarelin acetate gonadotropin-releasing hormone agonist treatment endometriosis erratum DICP Mar Nafarelin acetate gonadotropin-releasing hormone GnRH agonist effective danazol endometriosis mechanism action desensitization pituitary GnRH receptors decrease gonadotropin release ovarian hormone serum concentrations similar postmenopausal women Nafarelin physical symptoms endometriosis pregnancy rates therapy drug comparable rates danazol therapy Nafarelin nasal inhalation high incidence adverse effects severe withdrawal treatment hot flashes vaginal dryness libido consequence hypoestrogenemia drug bone turnover women nafarelin biochemical parameters concentrations months termination treatment agent place therapy endometriosis clinical experience accumulates 